AUM and trading activity drives Oppenheimer's wealth management business. Read why we remain bullish on OPY stock.
Oppenheimer analysts maintained an Outperform rating on Modine Manufacturing (NYSE:MOD) shares with a $145.00 price target.
About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...
2d
ScreenRant on MSNChristopher Nolan's Next Movie Is Already Surpassing Oppenheimer In 1 Big Way That Didn't Seem Like It Was PossibleChristopher Nolan’s next project is an adaptation of The Odyssey, and though Oppenheimer is his biggest project to date, his ...
Alphabet (GOOGL) will be stepping up to the earnings plate tomorrow (February 4), when it will deliver its fourth quarter ...
Oppenheimer (NYSE:OPY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Monday. Oppenheimer Trading ...
(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
YAVNE, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics ...
Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...
LEXINGTON, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company ...
U.K. home entertainment hits record $6.4 billion as 'Wonka' leads formats, with streaming and 'Dune 2,' 'Oppenheimer' driving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results